Pearce G - Search Results

1

Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist.

Sprecher DL, Massien C, Pearce G, Billin AN, Perlstein I, Willson TM, Hassall DG, Ancellin N, Patterson SD, Lobe DC, Johnson TG. Sprecher DL, et al. Among authors: pearce g. Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):359-65. doi: 10.1161/01.ATV.0000252790.70572.0c. Epub 2006 Nov 16. Arterioscler Thromb Vasc Biol. 2007. PMID: 17110604 Clinical Trial.

2

Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome.

Olson EJ, Pearce GL, Jones NP, Sprecher DL. Olson EJ, et al. Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2289-94. doi: 10.1161/ATVBAHA.112.247890. Epub 2012 Jul 19. Arterioscler Thromb Vasc Biol. 2012. PMID: 22814748 Clinical Trial.

3

Skin cholesterol adds to Framingham risk assessment.

Sprecher DL, Pearce GL. Sprecher DL, et al. Am Heart J. 2006 Oct;152(4):694-6. doi: 10.1016/j.ahj.2006.04.027. Am Heart J. 2006. PMID: 16996840

4

Elevated skin tissue cholesterol levels and myocardial infarction.

Sprecher DL, Pearce GL. Sprecher DL, et al. Atherosclerosis. 2005 Aug;181(2):371-3. doi: 10.1016/j.atherosclerosis.2005.01.022. Atherosclerosis. 2005. PMID: 16039292

5

Elevated fibrinogen and homocysteine levels enhance the risk of mortality in patients from a high-risk preventive cardiology clinic.

Acevedo M, Pearce GL, Kottke-Marchant K, Sprecher DL. Acevedo M, et al. Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):1042-5. doi: 10.1161/01.atv.0000020007.25154.62. Arterioscler Thromb Vasc Biol. 2002. PMID: 12067918

6

Fiber-multivitamin combination therapy: a beneficial influence on low-density lipoprotein and homocysteine.

Sprecher DL, Pearce GL. Sprecher DL, et al. Metabolism. 2002 Sep;51(9):1166-70. doi: 10.1053/meta.2002.34048. Metabolism. 2002. PMID: 12200762 Clinical Trial.

7

Skin tissue cholesterol (SkinTc) is related to angiographically-defined cardiovascular disease.

Sprecher DL, Goodman SG, Kannampuzha P, Pearce GL, Langer A. Sprecher DL, et al. Among authors: pearce gl. Atherosclerosis. 2003 Dec;171(2):255-8. doi: 10.1016/s0021-9150(03)00290-9. Atherosclerosis. 2003. PMID: 14644394 Clinical Trial.

8

Impact of nonprescriptive factors on low-density lipoprotein cholesterol reduction with statins.

Frolkis JP, Pearce GL, Sprecher DL. Frolkis JP, et al. Am J Cardiol. 2004 Nov 15;94(10):1310-2. doi: 10.1016/j.amjcard.2004.07.122. Am J Cardiol. 2004. PMID: 15541255

9

Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women.

Foody JM, Milberg JA, Robinson K, Pearce GL, Jacobsen DW, Sprecher DL. Foody JM, et al. Among authors: pearce gl. Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):493-9. doi: 10.1161/01.atv.20.2.493. Arterioscler Thromb Vasc Biol. 2000. PMID: 10669648

10

How deadly is the "deadly quartet"? A post-CABG evaluation.

Sprecher DL, Pearce GL. Sprecher DL, et al. Among authors: pearce gl. J Am Coll Cardiol. 2000 Oct;36(4):1159-65. doi: 10.1016/s0735-1097(00)00867-6. J Am Coll Cardiol. 2000. PMID: 11028465 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

424 results

Search Page